219 related articles for article (PubMed ID: 18483249)
1. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
[TBL] [Abstract][Full Text] [Related]
2. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
3. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
[TBL] [Abstract][Full Text] [Related]
4. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
Swart GW; Lunter PC; Kilsdonk JW; Kempen LC
Cancer Metastasis Rev; 2005 Jun; 24(2):223-36. PubMed ID: 15986133
[TBL] [Abstract][Full Text] [Related]
5. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A; Matysiak W; Motyl T
Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
[TBL] [Abstract][Full Text] [Related]
6. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
Ikeda K; Quertermous T
J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
[TBL] [Abstract][Full Text] [Related]
7. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
van Kempen LC; Meier F; Egeblad M; Kersten-Niessen MJ; Garbe C; Weidle UH; Van Muijen GN; Herlyn M; Bloemers HP; Swart GW
J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
[TBL] [Abstract][Full Text] [Related]
8. ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer.
Hong X; Michalski CW; Kong B; Zhang W; Raggi MC; Sauliunaite D; De Oliveira T; Friess H; Kleeff J
J Surg Oncol; 2010 Jun; 101(7):564-9. PubMed ID: 20461761
[TBL] [Abstract][Full Text] [Related]
9. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
[TBL] [Abstract][Full Text] [Related]
10. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism.
Uhlenbrock K; Eberth A; Herbrand U; Daryab N; Stege P; Meier F; Friedl P; Collard JG; Ahmadian MR
J Cell Sci; 2004 Sep; 117(Pt 20):4863-71. PubMed ID: 15340013
[TBL] [Abstract][Full Text] [Related]
11. ALCAM/CD166: cancer-related issues.
Weidle UH; Eggle D; Klostermann S; Swart GW
Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
[TBL] [Abstract][Full Text] [Related]
12. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
[TBL] [Abstract][Full Text] [Related]
13. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Yokoi K; Osada H; Sekido Y
J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789
[TBL] [Abstract][Full Text] [Related]
14. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.
Kristiansen G; Pilarsky C; Wissmann C; Stephan C; Weissbach L; Loy V; Loening S; Dietel M; Rosenthal A
Prostate; 2003 Jan; 54(1):34-43. PubMed ID: 12481253
[TBL] [Abstract][Full Text] [Related]
15. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
van Kempen LC; van den Oord JJ; van Muijen GN; Weidle UH; Bloemers HP; Swart GW
Am J Pathol; 2000 Mar; 156(3):769-74. PubMed ID: 10702391
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes.
Rauch SJ; Rosenkranz AC; Böhm A; Meyer-Kirchrath J; Hohlfeld T; Schrör K; Rauch BH
Vascul Pharmacol; 2011; 54(3-6):93-9. PubMed ID: 21440089
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
[TBL] [Abstract][Full Text] [Related]
18. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
Swart GW
Eur J Cell Biol; 2002 Jun; 81(6):313-21. PubMed ID: 12113472
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
[TBL] [Abstract][Full Text] [Related]
20. ALCAM (CD166) is a surface marker for early murine cardiomyocytes.
Hirata H; Murakami Y; Miyamoto Y; Tosaka M; Inoue K; Nagahashi A; Jakt LM; Asahara T; Iwata H; Sawa Y; Kawamata S
Cells Tissues Organs; 2006; 184(3-4):172-80. PubMed ID: 17409743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]